US 11834500
Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11834500 (Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K39/3955, A61K45/06